Publikationen in Zusammenarbeit mit Forschern von University of Salerno (6)

2016

  1. 1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention

    Journal of the American College of Cardiology, Vol. 68, Núm. 7, pp. 727-738

  2. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony

    International Journal of Cardiology, Vol. 221, pp. 359-363

  3. Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction

    American Journal of Cardiology, Vol. 118, Núm. 12, pp. 1798-1804

2015

  1. Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

    Vascular Pharmacology, Vol. 73, pp. 32-37

2014

  1. Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 114, Núm. 8, pp. 1145-1150

  2. Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: A pooled analysis of individual patient data from five randomised controlled trials

    EuroIntervention, Vol. 9, Núm. 9, pp. 1110-1120